Centessa Pharmaceuticals to Present at the Morgan Stanley Virtual 19th Annual Global Healthcare Conference

Rhea-AI Summary

Centessa Pharmaceuticals (Nasdaq: CNTA) announced that CEO Saurabh Saha will participate in an analyst-led fireside chat at the Morgan Stanley Virtual 19th Annual Global Healthcare Conference on September 14, 2021, at 5:00 p.m. ET. A live audio webcast will be available on the investor relations section of Centessa's website, with a replay accessible for 90 days post-event. Centessa focuses on bringing new medicines to patients through a specialized, asset-centric approach, targeting various therapeutic areas such as oncology and immunology.

CAMBRIDGE, Mass. & LONDON, Sept. 01, 2021 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA) announced today that Saurabh Saha, M.D., Ph.D., Chief Executive Officer, will participate in an analyst-led fireside chat at the Morgan Stanley Virtual 19th Annual Global Healthcare Conference on Tuesday, September 14, 2021, beginning at 5:00 p.m. Eastern Time.

A live audio webcast of this event can be accessed on the investor relations section of the Centessa Pharmaceuticals website at https://investors.centessa.com/events-presentations. Replay of the webcast will be archived on the Company's website for 90 days following the event.

About Centessa Pharmaceuticals
Centessa Pharmaceuticals plc aims to bring impactful new medicines to patients by combining the strengths of an asset-centric model with the benefits of scale and diversification typical of larger R&D organizations. The asset-centric model refers to a highly specialized, singular-focused company that is led by a team of well-recognized subject matter experts. Centessa’s asset-centric companies’ programs range from discovery-stage to late-stage development and include diverse therapeutic areas such as oncology, hematology, immunology/inflammation, neuroscience, hepatology, pulmonology and nephrology. For more information, visit www.centessa.com.

Contacts:

Investor Contact:	Media Contacts:
Jennifer Porcelli, Head of Investor Relations	US
Centessa Pharmaceuticals	Dan Budwick, 1AB
jennifer.porcelli@centessa.com	dan@1abmedia.com
	UK/Greater Europe
	Mary Clark & Shabnam Bashir, Optimum Strategic Communications
	centessa@optimumcomms.com
	Switzerland
	Marcus Veith, VEITHing Spirit
	marcus@vspirit.ch
	M: +41 79 20 75 111

FAQ

When is the analyst-led fireside chat for Centessa Pharmaceuticals (CNTA)?

The analyst-led fireside chat for Centessa Pharmaceuticals (CNTA) is scheduled for September 14, 2021, at 5:00 p.m. Eastern Time.

Where can I watch the Centessa Pharmaceuticals (CNTA) fireside chat?

You can watch the Centessa Pharmaceuticals (CNTA) fireside chat live on the investor relations section of their website.

Will the Centessa Pharmaceuticals (CNTA) fireside chat be available later?

Yes, a replay of the Centessa Pharmaceuticals (CNTA) fireside chat will be available for 90 days after the event.

What is Centessa Pharmaceuticals (CNTA) focusing on in its development programs?

Centessa Pharmaceuticals (CNTA) focuses on developing new medicines across various therapeutic areas including oncology, hematology, and immunology.